# A Study of the Correlation Between Pharmacokinetic and Pharmacodynamic Parameters of CellCept (Mycophenolate Mofetil).

> **NCT01292226** · PHASE2 · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 45 (actual)

## Conditions studied

- Kidney Transplantation

## Interventions

- **DRUG:** mycophenolate mofetil
- **DRUG:** antibody induction
- **DRUG:** Cyclosporine
- **DRUG:** corticosteroid

## Key facts

- **NCT ID:** NCT01292226
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-12
- **Primary completion:** 2008-09
- **Final completion:** 2008-09
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2016-05-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01292226

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01292226, "A Study of the Correlation Between Pharmacokinetic and Pharmacodynamic Parameters of CellCept (Mycophenolate Mofetil).". Retrieved via MORVS 2026-10-17 from https://api.morvs.ai/clinical/NCT01292226. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*